Suppr超能文献

人脑膜瘤中孕激素受体的免疫细胞化学研究

Immunocytochemical study of progesterone receptor in human meningioma.

作者信息

Perrot-Applanat M, Groyer-Picard M T, Kujas M

机构信息

Groupe de Recherches Hormones et Reproduction (INSERM U 135), Faculté de Médecine Paris Sud, Le Kremlin Bicêtre, France.

出版信息

Acta Neurochir (Wien). 1992;115(1-2):20-30. doi: 10.1007/BF01400586.

Abstract

Progesterone (PR) and oestrogen (ER) receptors were examined in meningiomas from 36 patients, using immunocytochemistry. The present experiments were performed to evaluate: (a) the presence and intracellular localization of these receptors, (b) whether PR immunostaining can be correlated (or not) with proliferation potential, as evaluated by histopathological features or the clinical evolution of this neuropathological tumour. Twenty six tumours (72%) tested were positive for PR but none for ER. The presence of PR immunostaining was more frequently observed in females (79% versus 58% in males) and premenopausal status (84% versus 3/5 in postmenopausal). Correlations of PR immunostaining with the histologic type showed 89% of meningothelial, 4/6 cases of transitional, 1/3 case of fibroblastic and 1/4 cases of anaplastic meningiomas to be immunostained for PR. Staining was confined to tumours arachnoidal cells. A heterogeneous distribution was observed in most PR-positive meningiomas. The preferential immunostaining in meningothelial histological types correlates with the presence of PR in normal arachnoidal cells. The proliferating potential of these meningiomas was evaluated by the immunostaining of an antigen only present in proliferating cells (Ki antigen). There was no significant correlation between PR status and the Ki labelling rate, or rapid clinical evolution. These data were compared with those previously reported. They confirm that the cellular biosynthesis of PR in meningiomas is not oestrogen regulated as it is in other sex steroid tissues, such as the breast and the endometrium.

摘要

采用免疫细胞化学方法对36例患者的脑膜瘤进行了孕激素(PR)和雌激素(ER)受体检测。进行本实验的目的是评估:(a)这些受体的存在及其细胞内定位;(b)PR免疫染色是否与增殖潜能相关(或不相关),增殖潜能通过组织病理学特征或这种神经病理性肿瘤的临床进展来评估。检测的26个肿瘤(72%)PR呈阳性,但ER均为阴性。PR免疫染色在女性中更常见(79%,男性为58%),且在绝经前状态下更常见(84%,绝经后为3/5)。PR免疫染色与组织学类型的相关性显示,89%的脑膜皮型、4/6例过渡型、1/3例纤维型和1/4例间变型脑膜瘤PR免疫染色阳性。染色仅限于肿瘤的蛛网膜细胞。在大多数PR阳性的脑膜瘤中观察到异质性分布。脑膜皮组织学类型中优先的免疫染色与正常蛛网膜细胞中PR的存在相关。通过仅在增殖细胞中存在的一种抗原(Ki抗原)的免疫染色来评估这些脑膜瘤的增殖潜能。PR状态与Ki标记率或快速的临床进展之间没有显著相关性。将这些数据与先前报道的数据进行了比较。它们证实脑膜瘤中PR的细胞生物合成不像在其他性类固醇组织(如乳腺和子宫内膜)中那样受雌激素调节。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验